Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men

Summary Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80...

Full description

Saved in:
Bibliographic Details
Published in:Journal der Deutschen Dermatologischen Gesellschaft 2011-10, Vol.9 (s6), p.S1-S57
Main Authors: Blumeyer, Anja, Tosti, Antonella, Messenger, Andrew, Reygagne, Pascal, del Marmol, Veronique, Spuls, Phyllis I., Trakatelli, Myrto, Finner, Andreas, Kiesewetter, Franklin, Trüeb, Ralph, Rzany, Berthold, Blume-Peytavi, Ulrike
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
alopecia
Alopecia - diagnosis
Alopecia - etiology
Alopecia - therapy
androgenetic
Evidence-Based Medicine
Female
Guideline
hair loss
Humans
Male
Middle Aged
Randomized Controlled Trials as Topic
Therapy
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80 % Caucasian men and 42 % of women. Patients diagnosed with androgenetic alopecia may undergo significant impairment of quality of life. Despite the high prevalence and the variety of therapeutic options available, there have been no national or international evidence‐based guidelines for the treatment of androgenetic alopecia in men and women so far. Therefore, the European Dermatology Forum (EDF) initiated a project to develop an evidence‐based S3 guideline for the treatment of andro‐genetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists as well as general practitioners with an evidence‐based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
ISSN:1610-0379
1610-0387
DOI:10.1111/j.1610-0379.2011.07802.x